Amyloid beta peptides mediate hypoxic augmentation of Ca(2+) channels

J Neurochem. 2001 May;77(3):953-6. doi: 10.1046/j.1471-4159.2001.00338.x.

Abstract

Clinical studies indicate that neurodegeneration caused by Alzheimer's amyloid beta peptide (AbetaP) formation can be triggered or induced by prolonged (chronic) hypoxia. Here, we demonstrate that 24-h culture of PC12 cells in 10% O(2) leads to induction of a Cd(2+)-resistant Ca(2+) influx pathway and selective potentiation of L-type Ca(2+) current. Both effects were suppressed or prevented by a monoclonal antibody raised against the N'-terminus of AbetaP, and were fully mimicked by AbetaP(1-40 and) AbetaP(1-42), but not by AbetaP(40-1). Potentiation of L-type currents was also induced by exposure to AbetaP(25-35). Our results indicate that hypoxia induces enhancement of Ca(2+) channels, which is mediated by increased AbetaP formation.

MeSH terms

  • Amyloid beta-Peptides / immunology
  • Amyloid beta-Peptides / pharmacology*
  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Cadmium / pharmacology
  • Calcium / metabolism
  • Calcium Channels / physiology*
  • Calcium Channels, L-Type / physiology
  • Cell Hypoxia*
  • Drug Resistance
  • Drug Synergism
  • Electric Conductivity
  • Oxygen / administration & dosage
  • PC12 Cells
  • Peptide Fragments / immunology
  • Peptide Fragments / pharmacology
  • Rats

Substances

  • Amyloid beta-Peptides
  • Antibodies, Monoclonal
  • Calcium Channels
  • Calcium Channels, L-Type
  • Peptide Fragments
  • Cadmium
  • Oxygen
  • Calcium